Ozempic Shortage 2026: What to Take Instead (And Why Compounded Might Be Better)

# Ozempic Shortage 2026: What to Take Instead (And Why Compounded Might Be Better)

If you've been trying to get Ozempic and hitting dead ends — pharmacies out of stock, prior authorizations denied, your dose tier unavailable — you're not alone. Supply disruptions have been the defining story of the GLP-1 boom, and while things have improved somewhat from the peak shortage of 2023-2024, patients on Ozempic still face unpredictable access issues in 2026.

The good news: the alternatives aren't just stopgaps. For many patients, they're outright superior.

Why Ozempic Is Still Unreliable

Novo Nordisk's manufacturing capacity has struggled to keep pace with the massive uptick in demand driven by GLP-1's reputation for weight loss. While Ozempic was originally approved for type 2 diabetes management, off-label prescribing for weight loss created demand the company simply couldn't meet.

FDA shortage declarations came and went, but the underlying supply chain reality — that scaling pharmaceutical manufacturing takes years — remains a constraint. In 2026, the shortage is less acute than in 2023, but specific dosage strengths regularly go out of stock at pharmacies across the country.

The result: patients starting on 0.25mg or 0.5mg semaglutide often can't reliably advance to maintenance doses (1mg, 2mg) because their pharmacy runs out at exactly the wrong time.

Your Real Options in 2026

### Option 1: Compounded Semaglutide

The most popular alternative — and the one that has produced the most consistent results during the shortage period — is compounded semaglutide from FDA-registered compounding pharmacies.

What it is: Compounded semaglutide contains the same active ingredient as Ozempic/Wegovy. It's mixed by licensed compounding pharmacists to the dose specified by your physician.

The cost advantage is significant: Brand Ozempic runs $900-1,400/month without insurance. Compounded semaglutide from a quality telehealth platform runs $249-399/month — and that often includes physician oversight.

What to look for in a compounding pharmacy: - 503B outsourcing facilities (FDA-registered, higher manufacturing standards) - Third-party testing for sterility, potency, and purity - Vials and syringes included (not just the API without instructions)

The shortage edge: No shortage. Because compounded pharmacies mix to order within their licensed supply chain, they don't face the same retail shortage dynamics as Novo Nordisk's branded product.

### Option 2: Tirzepatide (Mounjaro/Zepbound, or Compounded)

Tirzepatide is a dual GIP/GLP-1 agonist — it targets two receptors instead of one, which is why clinical trials showed weight loss results averaging 20-22% of body weight, significantly outperforming semaglutide's 12-15%.

When to consider switching: If you've been on semaglutide for 3+ months and plateau'd, or if you're just starting and want the most powerful approved option, tirzepatide is worth discussing with your physician.

The shortage situation: Eli Lilly has been building out manufacturing more aggressively than Novo Nordisk, and compounded tirzepatide is widely available.

Cost: Compounded tirzepatide runs $299-499/month depending on dose. Brand-name Mounjaro/Zepbound is $1,000-1,300+ without insurance.

### Option 3: Stay on Ozempic and Use a Concierge Pharmacy Network

Some telehealth platforms have relationships with regional pharmacy networks that have better access to brand-name semaglutide. If you have insurance coverage and a strong preference for brand-name Ozempic specifically, this is the path — but expect to pay time and energy managing inventory.

Why Many Patients Never Go Back to Brand-Name

The shortage has inadvertently introduced a large population of patients to compounded semaglutide, and many who've tried it prefer it — for reasons that have nothing to do with the shortage.

Flexible dosing: Brand Ozempic comes in 0.25mg, 0.5mg, 1mg, and 2mg fixed pens. Compounded semaglutide can be dosed in smaller increments — useful for patients who want to microdose (take a smaller maintenance dose after reaching goal weight) or who had side effects at standard doses.

Cost: Even patients with good insurance often find their out-of-pocket cost for brand-name is higher than the full price of compounded semaglutide once copays and deductibles are factored in.

Continuity: No going to multiple pharmacies. No month-to-month supply anxiety.

Custom formulations: Some compounding pharmacies offer semaglutide in combinations with B12, L-carnitine, or other metabolic co-factors. Evidence for additive benefit is preliminary, but the flexibility is appealing to optimization-minded patients.

The Safety Question: Is Compounded Semaglutide Safe?

This is the question that gets the most anxiety, so let's be direct: quality matters enormously.

Semaglutide compounded by a legitimate 503B FDA-registered outsourcing facility with independent third-party testing is a different product — in terms of safety and reliability — from semaglutide compounded by a small, unregulated gray-market operation selling on websites with no physician oversight.

What you're looking for: - Physician consultation before prescribing (not just an online questionnaire auto-approving anything) - Pharmacy: 503B outsourcing facility or clearly reputable 503A compound pharmacy - Testing: third-party certificates of analysis available - Transparency about what's in the vial and how to inject correctly

Platforms that meet these criteria include Marrow and a few other regulated telehealth companies. What you want to avoid is unbranded "research peptides" selling semaglutide as "not for human use" — that's a regulatory fiction that means "we're not going to verify purity or dosing."

What to Ask Your Telehealth Provider

If you're considering switching from Ozempic to a compounded alternative, here are the questions that matter:

1. What compounding pharmacy do you use, and is it 503B registered?
2. Do you have certificates of analysis from third-party testing?
3. What's included in the price? (vials, syringes, physician consults, dose adjustments)
4. If I have a side effect issue, how quickly can I reach someone?
5. What's your dose titration protocol?

The answers tell you quickly whether you're dealing with a legitimate clinical operation or a prescription-light mail-order model.

The Bottom Line

The Ozempic shortage created a forced experiment that's changed how many patients think about GLP-1 access. Compounded semaglutide from reputable sources works, costs far less, and offers more flexibility. Tirzepatide is the stronger option if you're starting fresh. Brand-name Ozempic still has its place — but supply unpredictability has made it a less reliable foundation for a multi-month treatment protocol.

If you've been sitting on the sidelines because you couldn't get Ozempic, the alternatives are not a compromise. For most patients, they're the better path.